EarningsQ3 2025 Earnings Report

Teva Pharmaceutical (TEVAN) Q3 2025 Earnings Report

0 Followers

MX:TEVAN Q3 2025 EPS Results

Actual EPS$13.19

Consensus EPS$11.67

Beat/MissBeat by +$1.52

One Year Ago EPS$11.67

Actual Revenue$75.97B

Expected Revenue$73.66B

Beat/MissBeat by +$2.31B

YoY Revenue Growth+3.17%

QuarterQ3 2025

Date11/05/2025

TimeBefore Open

Conference CallWednesday, November 5, 2025

MX:TEVAN Upcoming Earnings

Teva Pharmaceutical's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

MX:TEVAN Q3 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	11.80 / -	13.191	―
Jul 29, 2026	2026 (Q2)	0.88 / 0.34	11.162	-96.97% (-10.82)
Apr 29, 2026	2026 (Q1)	7.97 / 8.96	8.794	1.92% (+0.17)
Jan 28, 2026	2025 (Q4)	10.84 / 16.24	12.008	35.21% (+4.23)
Nov 05, 2025	2025 (Q3)	11.67 / 13.19	11.669	13.04% (+1.52)
Jul 30, 2025	2025 (Q2)	10.43 / 11.16	10.316	8.20% (+0.85)
May 07, 2025	2025 (Q1)	7.81 / 8.79	8.118	8.33% (+0.68)
Jan 29, 2025	2024 (Q4)	11.96 / 12.01	16.912	-29.00% (-4.90)
Nov 06, 2024	2024 (Q3)	11.18 / 11.67	10.147	15.00% (+1.52)
Jul 31, 2024	2024 (Q2)	9.34 / 10.32	9.471	8.93% (+0.85)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed